BPI 2026 has ended. This guide stays up as the record of who was there. Next: BPI 2027, Sep 20–23, 2027 in Boston

Kemwell Biopharma at BPI 2026

Sep 22–25, 2026 Boston, MA ~3k attendees Website

Kemwell Biopharma takes part in 1 session at BPI 2026 in Boston, and exhibits at Booth 515. Kemwell Biopharma is a CDMO that develops processes and makes protein therapeutics from mammalian cells for clinical and commercial use. Its session covers scaling downstream processes from the lab to GMP manufacturing.

OrganizationBPI 2026 Attendance
Kemwell Biopharma
Bengaluru, India
CDMO & CROExhibitor
Biologics CDMO providing process development and clinical and commercial manufacturing of mammalian-cell-derived protein therapeutics.
Booth
Exhibiting at Booth 515
Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm
Panel
Wed Sep 23
2:00pm–2:30pm
PANEL DISCUSSION: Scaling Downstream Processes: From Lab to GMP Manufacturing
Downstream Processing · with Hinge Bio, Amgen, University College London +1 more

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Kemwell Biopharma

Tell us what you sell and we’ll find the people at Kemwell Biopharma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the BioProcess International Conference & Exhibition or its organizers. Submit a correction